Cargando…
Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment
Recent development of monoclonal antibodies as mainstream anticancer agents demands further optimization of their safety for use in humans. Potent targeting and/or effector activities on normal tissues is an obvious toxicity concern. Optimization of specific tumor targeting could be achieved by taki...
Autores principales: | Sulea, Traian, Rohani, Nazanin, Baardsnes, Jason, Corbeil, Christopher R., Deprez, Christophe, Cepero-Donates, Yuneivy, Robert, Alma, Schrag, Joseph D., Parat, Marie, Duchesne, Mélanie, Jaramillo, Maria L., Purisima, Enrico O., Zwaagstra, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927761/ https://www.ncbi.nlm.nih.gov/pubmed/31777319 http://dx.doi.org/10.1080/19420862.2019.1682866 |
Ejemplares similares
-
Structure-based dual affinity optimization of a SARS-CoV-1/2 cross-reactive single-domain antibody
por: Sulea, Traian, et al.
Publicado: (2022) -
Binding and functional profiling of antibody mutants guides selection of optimal candidates as antibody drug conjugates
por: Zwaagstra, John C., et al.
Publicado: (2019) -
A glyco-engineering approach for site-specific conjugation to Fab glycans
por: Jaramillo, Maria L., et al.
Publicado: (2022) -
Solvated interaction energy: from small-molecule to antibody drug design
por: Purisima, Enrico O., et al.
Publicado: (2023) -
Exploring rigid-backbone protein docking in biologics discovery: a test using the DARPin scaffold
por: Gaudreault, Francis, et al.
Publicado: (2023)